Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended
Sep. 30, 2017	Sep. 30, 2016
Revenue	$ 32,641	$ 32,039
Cost of products sold	30,969	30,449
Gross margin	1,672	1,590
Operating expenses:
Distribution, selling, general and administrative expenses	1,062	920
Restructuring and employee severance	132	9
Amortization and other acquisition-related costs	183	122
Impairments and (gain)/loss on disposal of assets, net	1	3
Litigation (recoveries)/charges, net	32	1
Operating earnings	262	535
Other (income)/expense, net	2	(3)
Interest expense, net	81	44
Loss on extinguishment of debt	1	0
Earnings before income taxes	178	494
Provision for income taxes	61	184
Net earnings	117	310
Net earnings attributable to noncontrolling interests	(2)	(1)
Net earnings attributable to Cardinal Health, Inc.	$ 115	$ 309
Earnings per common share attributable to Cardinal Health, Inc.:
Basic (in shares)	$ 0.36	$ 0.97
Diluted (in shares)	$ 0.36	$ 0.96
Weighted-average number of common shares outstanding:
Basic (in shares)	316	320
Diluted (in shares)	318	322
Cash dividends declared per common share	$ 0.4624	$ 0.4489

The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

No definition available.